Suven Pharmaceuticals Limited (BOM:543064)

Suven Pharmaceuticals Statistics

Total Valuation

BOM:543064 has a market cap or net worth of INR 273.42 billion. The enterprise value is 267.75 billion.

Market Cap	273.42B
Enterprise Value	267.75B

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.37%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	101.45M

Valuation Ratios

The trailing PE ratio is 97.92.

PE Ratio	97.92
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	16.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	95.89
EV / Sales	25.54
EV / EBITDA	73.13
EV / EBIT	86.28
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	0.11
Debt / FCF	n/a
Interest Coverage	34.86

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	9.50%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	8.79M
Profits Per Employee	2.34M
Employee Count	1,193
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +71.42% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+71.42%
50-Day Moving Average	1,123.19
200-Day Moving Average	1,103.63
Relative Strength Index (RSI)	40.50
Average Volume (20 Days)	10,891

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:543064 had revenue of INR 10.48 billion and earned 2.79 billion in profits. Earnings per share was 10.93.

Revenue	10.48B
Gross Profit	6.58B
Operating Income	3.10B
Pretax Income	3.63B
Net Income	2.79B
EBITDA	3.66B
EBIT	3.10B
Earnings Per Share (EPS)	10.93

Balance Sheet

The company has 6.56 billion in cash and 394.60 million in debt, giving a net cash position of 6.16 billion.

Cash & Cash Equivalents	6.56B
Total Debt	394.60M
Net Cash	6.16B
Net Cash Per Share	n/a
Equity (Book Value)	20.28B
Book Value Per Share	77.73
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 62.78%, with operating and profit margins of 29.60% and 26.63%.

Gross Margin	62.78%
Operating Margin	29.60%
Pretax Margin	34.64%
Profit Margin	26.63%
EBITDA Margin	34.92%
EBIT Margin	29.60%
FCF Margin	n/a

Dividends & Yields

BOM:543064 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.37%
Shareholder Yield	-0.37%
Earnings Yield	1.02%
FCF Yield	n/a

Stock Splits

The last stock split was on September 25, 2020. It was a forward split with a ratio of 2.

Last Split Date	Sep 25, 2020
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a